Every step of scientific and technological innovation is inseparable from extensive cooperation and exchanges. At the sub-venue of the 2024 China Health Science and Technology Innovation and Discipline Construction Conference and the High-quality Development Conference of Chinese-style Modern Hospitals, the participants focused on the scientific research innovation of medical education in universities, the clinical transformation of cutting-edge medicine, and the practical application of scientific and technological achievements.
Create a market-oriented system for the transformation and application of scientific and technological achievements
Jin Cong
Director of the Achievement Division of Zhejiang Provincial Department of Science and Technology
Jin Cong, Director of the Achievement Division of Zhejiang Provincial Department of Science and Technology: Zhejiang Province is building a more systematic and market-oriented system for the transformation and application of scientific and technological achievements, solving the problem of fragmentation in the transformation of achievements, and putting forward the principles of "three insistences" and "three wholes". The former is to adhere to problem-oriented, systematic thinking, and integrity, while the latter is to promote "the whole chain, the whole cycle, and all elements".
Specifically, Zhejiang Province is problem-solving-oriented, and solves the problem of blocking points in the transformation of achievements in the whole chain; Dynamic promotion of the whole cycle, closed-loop management, and solving the problems of service system and enterprise needs; Give full play to the capabilities of governments at all levels, colleges and universities, enterprises and other entities, and form a specialized division of labor.
At the same time, Zhejiang Province has also promoted the transformation of scientific and technological achievements through the construction of "peace of mind house", "Taobao" and "large corps". The "Anxin House" is an official platform for the management, transformation and approval, income distribution and listing and trading of scientific and technological achievements, which can solve the problems caused by the attributes of state-owned assets. "Taobao" determines the price of achievements through auctions, builds a management system for the reduction of transformation risks, and reduces the risk of achievement transformation. The "big corps" of the science and technology service system emphasizes the importance of technology brokers, and enhances the status and income of brokers through the technology market platform.
In addition, Zhejiang Province has also introduced policies to allow the results to be used for free before being transformed, reducing transaction costs and increasing the success rate. Zhejiang Province promotes the linkage of various policy resources and supports industrial development through special actions, roundtables and other mechanisms; Cultivate and introduce science and technology service institutions to ensure that the transformation of achievements can be supervised.
Innovation is a key measure to improve the productivity of new qualities
Song Zhangfa
Vice President of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Song Zhangfa, Vice President of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine: Innovation is the first driving force to lead development and an effective way to improve people's quality of life. Facing people's lives and health, innovation can better meet people's yearning for a better life. Carrying out cutting-edge medical science and technology innovation and achievement transformation is an important part of the construction of a new system for high-quality development of public hospitals, and it is also a key measure for public hospitals to improve the productivity of new quality. Hospitals are the main battlefield for solving the problems of difficult and critical illnesses of the people. Medical personnel are the proposers of clinical needs, the inventors of medical innovations, the facilitators of technological inventions, the executors of clinical trials, and the users of pharmaceutical products. It can be seen that high-level public hospitals are at the junction of innovation chain, industrial chain and application chain, and are also key hubs connecting patients, universities, research institutes and enterprises.
We should not only transform patients' demands into technical problems and accurately reflect them to research institutions and related enterprises, but also carry out clinical research from the direction of disease prevention and control, create a number of products for the transformation of medical innovation achievements, and promote the solution of "bottleneck" problems such as drugs, medical equipment, and vaccines.
Engage more students in innovation
At the same time, a display session was set up at the conference, showing a number of new clinical diagnosis and treatment methods and biomaterial application innovations, including new magnetic resonance contrast agent and tumor diagnosis and treatment integrated nanomedicine, colorectal cancer serum peptide detection kit (mass spectrometry), one-step method to construct "colloidal + cell sheet" composite film and repair skin damage, immersive virtual reality technology in self-learning training cardiopulmonary resuscitation, etc.
Huang Zhen
Vice President of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Huang Hui, moderator of the exhibition session and vice president of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine: Translating scientific research results into practical applications is the key to promoting the development of medicine. Students have great potential in innovation and entrepreneurship, not only to bring new vitality to medical research, but also to promote the transformation of scientific research results and have a positive impact on society. It should be reminded that in the process of innovation, we should pay attention to the close combination of clinical needs and scientific research innovation, and strengthen multidisciplinary cross-cooperation.
Gu Chenhui, Ph.D. student, Zhejiang University School of Medicine: As a student innovation and entrepreneurship practitioner, we have successfully carried out a number of innovative activities with the help of various policies of the school and the hospital, and achieved a series of results, including the use of baking soda liposomes to treat osteoporosis, and the use of platelet nanotechnology to treat diabetic foot. In the future, we will continue to innovate and contribute to the advancement of medicine.
Create a good atmosphere for continuous innovation of medical talents
Ping-hsien
Deputy Director of the Academic Affairs Office of Sichuan University, Director of the Medical Teaching Department and Associate Researcher of West China Medical Center, Sichuan University
Qing Ping, Deputy Director of the Academic Affairs Office of Sichuan University, Director of the Medical Education Department and Associate Researcher of West China Medical Center, Sichuan University: The "integration of hospitals and hospitals" model of West China Hospital emphasizes the close integration of medical education and clinical practice, as well as the core position of teaching in the training of medical students. At the same time, we should pay attention to the investment of teaching resources and the construction of teaching culture.
The main feature of the "integration of hospitals and hospitals" is that medical students are in a hospital environment from enrollment to graduation, and the teaching plan is based on the opinions of doctors, emphasizing the role of hospitals in education and professional training. At the same time, West China Medical Center integrates the resources of the four affiliated hospitals and related schools to jointly build and share teaching research and faculty resources. The hospital also gives teaching an important place. For example, the hospital has a department and personnel dedicated to teaching to provide professional services. The hospital invests in the development of teaching materials to ensure that teachers can focus on developing high-quality teaching materials. In addition, the hospital creates continuous teaching activities and culture, such as regular teaching rounds.
Zhao Bin
Director of the Achievements and Intellectual Property Department of the Institute of Science and Technology, Zhejiang University
Zhao Bin, Director of the Achievement and Intellectual Property Department of the Institute of Science and Technology, Zhejiang University: For medical innovation practitioners, the award application needs to be planned in advance. Everyone should focus on the core theories and technologies, clarify the innovation points, and carefully write the project introduction. The project brief is the most interesting part of the judging process, and it should have a story and impact, and be accompanied by circumstantial evidence to avoid being questioned. Applicants can select three core innovation points to refine and describe them in plain language. At the same time, we should also pay attention to the third-party evaluation, including the number of papers, citations, positive evaluations, etc., and prepare sufficient supporting materials, such as search reports, novelty search reports, appraisal certificates, etc. It should be emphasized that we have zero tolerance for duplicate awards, academic misconduct and other behaviors, and severely crack down on patchwork and hitchhiking.
Accelerate China's innovative drugs to "go global"
Yan Li
Managing Director of the U.S.-China Anti-Cancer Association, Ph.D
Dr. Yan Li, Executive Director of the US-China Anti-Cancer Association: To achieve the success of domestic innovative drugs in the global pharmaceutical market, the "going overseas" of innovative drugs is a key part. "Going overseas" of innovative drugs is a complex but potential process, which requires the joint efforts of pharmaceutical companies, governments, capital and medical professionals. Although the market demand in mainland China is huge, the "going overseas" of innovative drugs can better reflect the value of products. At present, a number of original drugs in mainland China are marketed in the United States. The relevant original drug companies have adopted different strategies of "going global", such as building their own overseas teams, cooperative development, licensing, etc.
In general, pharmaceutical companies need to be in awe of innovation, the government should provide financial and environmental support, and the market environment needs to be more mature to support the industry. Doctors play a key role in clinical trials, and they should be encouraged to guide pharmaceutical companies to stop losses in time when they see adverse results.
Finishing: Health News reporter Wang Xiaoyu
Curator: Li Tianshu, Tan Jia
Editor: Xia Haibo Guan Zhongyao
Proofreading: Ma Yang
Review: Qin Mingrui, Xu Bingnan
This article has been certified by the "original" original, the author Health News Co., Ltd., visit yuanben.io query [1Y8R1GK4] for authorization